Designer Cellular Spheroids with DNA Origami for Drug Screening

Author:

Pei Hao1ORCID,Wei Jiayi2ORCID,Sun Yueyang1,Wang Heming2,Zhu Tong1ORCID,Li Li1ORCID,Zhou Ying1,Liu Quan3ORCID,Dai Zhen4,Li Wenjuan5ORCID,Yang Taihua6,Wang Bingmei7,Zhu Changfeng2ORCID,Shen Xizhong8,Yao Qunyan2,Song Guangqi9,Zhao Yicheng10ORCID

Affiliation:

1. East China Normal University

2. Fudan University

3. Jilin University

4. Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences

5. Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences

6. Shanghai Jiaotong University

7. Changchun University of Chinese Medicine

8. Department of Gastroenterology, Zhongshan Hospital of Fudan University, Shanghai, China.

9. Puheng Technology

10. The First Hospital of Jilin University

Abstract

Abstract In vitro models are crucial for drug screening, yet they often fail to accurately reflect human physiological responses. While 3D cell cultures aim to simulate human tissues, many lack the detailed complexity and interaction of various cell types found in actual tissues. Additionally, integrating these models with high-throughput drug screening remains a challenge. Current models can't strike the balance between capturing the complexity of human diseases and being suitable for large-scale drug tests. Here we introduce a method that uses self-assembling Nucleic-Acid-nanostructures-decorated-living-Cells, termed NACs, to create spheroids with a customizable 3D layout. To demonstrate its uniqueness, our method effectively creates designer 3D liver spheroids by combining hepatocytes with different non-parenchymal cells, leading to improved drug sensitivity and detailed modeling of complex chronic diseases and immune-stromal interactions. Our approach achieves a high level of biological detail while being standardized and straightforward to construct with the potential for large-scale drug discovery applications. By combining the precision of DNA nanotechnology with advanced cell culture techniques, we're streamlining human-centric models, balancing complexity with standardization, to boost drug screening efficiency.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3